1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Demineralized Bone Matrix and Demineralized Allograft Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Demineralized Bone Matrix and Demineralized Allograft by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Demineralized Bone Matrix and Demineralized Allograft by Country/Region, 2018, 2022 & 2029
2.2 Demineralized Bone Matrix and Demineralized Allograft Segment by Type
2.2.1 Gel
2.2.2 Putty
2.2.3 Putty with Chips
2.2.4 Others
2.3 Demineralized Bone Matrix and Demineralized Allograft Sales by Type
2.3.1 Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Type (2018-2023)
2.3.2 Global Demineralized Bone Matrix and Demineralized Allograft Revenue and Market Share by Type (2018-2023)
2.3.3 Global Demineralized Bone Matrix and Demineralized Allograft Sale Price by Type (2018-2023)
2.4 Demineralized Bone Matrix and Demineralized Allograft Segment by Application
2.4.1 Dental Surgery
2.4.2 Spine Surgery
2.4.3 Trauma Surgery
2.5 Demineralized Bone Matrix and Demineralized Allograft Sales by Application
2.5.1 Global Demineralized Bone Matrix and Demineralized Allograft Sale Market Share by Application (2018-2023)
2.5.2 Global Demineralized Bone Matrix and Demineralized Allograft Revenue and Market Share by Application (2018-2023)
2.5.3 Global Demineralized Bone Matrix and Demineralized Allograft Sale Price by Application (2018-2023)
3 Global Demineralized Bone Matrix and Demineralized Allograft by Company
3.1 Global Demineralized Bone Matrix and Demineralized Allograft Breakdown Data by Company
3.1.1 Global Demineralized Bone Matrix and Demineralized Allograft Annual Sales by Company (2018-2023)
3.1.2 Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Company (2018-2023)
3.2 Global Demineralized Bone Matrix and Demineralized Allograft Annual Revenue by Company (2018-2023)
3.2.1 Global Demineralized Bone Matrix and Demineralized Allograft Revenue by Company (2018-2023)
3.2.2 Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Company (2018-2023)
3.3 Global Demineralized Bone Matrix and Demineralized Allograft Sale Price by Company
3.4 Key Manufacturers Demineralized Bone Matrix and Demineralized Allograft Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Demineralized Bone Matrix and Demineralized Allograft Product Location Distribution
3.4.2 Players Demineralized Bone Matrix and Demineralized Allograft Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Demineralized Bone Matrix and Demineralized Allograft by Geographic Region
4.1 World Historic Demineralized Bone Matrix and Demineralized Allograft Market Size by Geographic Region (2018-2023)
4.1.1 Global Demineralized Bone Matrix and Demineralized Allograft Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Demineralized Bone Matrix and Demineralized Allograft Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Demineralized Bone Matrix and Demineralized Allograft Market Size by Country/Region (2018-2023)
4.2.1 Global Demineralized Bone Matrix and Demineralized Allograft Annual Sales by Country/Region (2018-2023)
4.2.2 Global Demineralized Bone Matrix and Demineralized Allograft Annual Revenue by Country/Region (2018-2023)
4.3 Americas Demineralized Bone Matrix and Demineralized Allograft Sales Growth
4.4 APAC Demineralized Bone Matrix and Demineralized Allograft Sales Growth
4.5 Europe Demineralized Bone Matrix and Demineralized Allograft Sales Growth
4.6 Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales Growth
5 Americas
5.1 Americas Demineralized Bone Matrix and Demineralized Allograft Sales by Country
5.1.1 Americas Demineralized Bone Matrix and Demineralized Allograft Sales by Country (2018-2023)
5.1.2 Americas Demineralized Bone Matrix and Demineralized Allograft Revenue by Country (2018-2023)
5.2 Americas Demineralized Bone Matrix and Demineralized Allograft Sales by Type
5.3 Americas Demineralized Bone Matrix and Demineralized Allograft Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Demineralized Bone Matrix and Demineralized Allograft Sales by Region
6.1.1 APAC Demineralized Bone Matrix and Demineralized Allograft Sales by Region (2018-2023)
6.1.2 APAC Demineralized Bone Matrix and Demineralized Allograft Revenue by Region (2018-2023)
6.2 APAC Demineralized Bone Matrix and Demineralized Allograft Sales by Type
6.3 APAC Demineralized Bone Matrix and Demineralized Allograft Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Demineralized Bone Matrix and Demineralized Allograft by Country
7.1.1 Europe Demineralized Bone Matrix and Demineralized Allograft Sales by Country (2018-2023)
7.1.2 Europe Demineralized Bone Matrix and Demineralized Allograft Revenue by Country (2018-2023)
7.2 Europe Demineralized Bone Matrix and Demineralized Allograft Sales by Type
7.3 Europe Demineralized Bone Matrix and Demineralized Allograft Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft by Country
8.1.1 Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales by Country (2018-2023)
8.1.2 Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Revenue by Country (2018-2023)
8.2 Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales by Type
8.3 Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Demineralized Bone Matrix and Demineralized Allograft
10.3 Manufacturing Process Analysis of Demineralized Bone Matrix and Demineralized Allograft
10.4 Industry Chain Structure of Demineralized Bone Matrix and Demineralized Allograft
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Demineralized Bone Matrix and Demineralized Allograft Distributors
11.3 Demineralized Bone Matrix and Demineralized Allograft Customer
12 World Forecast Review for Demineralized Bone Matrix and Demineralized Allograft by Geographic Region
12.1 Global Demineralized Bone Matrix and Demineralized Allograft Market Size Forecast by Region
12.1.1 Global Demineralized Bone Matrix and Demineralized Allograft Forecast by Region (2024-2029)
12.1.2 Global Demineralized Bone Matrix and Demineralized Allograft Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Demineralized Bone Matrix and Demineralized Allograft Forecast by Type
12.7 Global Demineralized Bone Matrix and Demineralized Allograft Forecast by Application
13 Key Players Analysis
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
13.1.3 Medtronic Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 J &J (DePuy Synthes)
13.2.1 J &J (DePuy Synthes) Company Information
13.2.2 J &J (DePuy Synthes) Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
13.2.3 J &J (DePuy Synthes) Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 J &J (DePuy Synthes) Main Business Overview
13.2.5 J &J (DePuy Synthes) Latest Developments
13.3 SeaSpine
13.3.1 SeaSpine Company Information
13.3.2 SeaSpine Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
13.3.3 SeaSpine Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 SeaSpine Main Business Overview
13.3.5 SeaSpine Latest Developments
13.4 Xtant Medical
13.4.1 Xtant Medical Company Information
13.4.2 Xtant Medical Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
13.4.3 Xtant Medical Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Xtant Medical Main Business Overview
13.4.5 Xtant Medical Latest Developments
13.5 Zimmer Biomet
13.5.1 Zimmer Biomet Company Information
13.5.2 Zimmer Biomet Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
13.5.3 Zimmer Biomet Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Zimmer Biomet Main Business Overview
13.5.5 Zimmer Biomet Latest Developments
13.6 Stryker
13.6.1 Stryker Company Information
13.6.2 Stryker Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
13.6.3 Stryker Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Stryker Main Business Overview
13.6.5 Stryker Latest Developments
13.7 Straumann
13.7.1 Straumann Company Information
13.7.2 Straumann Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
13.7.3 Straumann Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Straumann Main Business Overview
13.7.5 Straumann Latest Developments
13.8 Wright Medical Group
13.8.1 Wright Medical Group Company Information
13.8.2 Wright Medical Group Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
13.8.3 Wright Medical Group Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Wright Medical Group Main Business Overview
13.8.5 Wright Medical Group Latest Developments
13.9 Hans Biomed
13.9.1 Hans Biomed Company Information
13.9.2 Hans Biomed Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
13.9.3 Hans Biomed Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Hans Biomed Main Business Overview
13.9.5 Hans Biomed Latest Developments
13.10 Arthrex
13.10.1 Arthrex Company Information
13.10.2 Arthrex Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
13.10.3 Arthrex Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Arthrex Main Business Overview
13.10.5 Arthrex Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Demineralized Bone Matrix and Demineralized Allograft Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Demineralized Bone Matrix and Demineralized Allograft Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Gel
Table 4. Major Players of Putty
Table 5. Major Players of Putty with Chips
Table 6. Major Players of Others
Table 7. Global Demineralized Bone Matrix and Demineralized Allograft Sales by Type (2018-2023) & (K Units)
Table 8. Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Type (2018-2023)
Table 9. Global Demineralized Bone Matrix and Demineralized Allograft Revenue by Type (2018-2023) & ($ million)
Table 10. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Type (2018-2023)
Table 11. Global Demineralized Bone Matrix and Demineralized Allograft Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Demineralized Bone Matrix and Demineralized Allograft Sales by Application (2018-2023) & (K Units)
Table 13. Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Application (2018-2023)
Table 14. Global Demineralized Bone Matrix and Demineralized Allograft Revenue by Application (2018-2023)
Table 15. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Application (2018-2023)
Table 16. Global Demineralized Bone Matrix and Demineralized Allograft Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Demineralized Bone Matrix and Demineralized Allograft Sales by Company (2018-2023) & (K Units)
Table 18. Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Company (2018-2023)
Table 19. Global Demineralized Bone Matrix and Demineralized Allograft Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Company (2018-2023)
Table 21. Global Demineralized Bone Matrix and Demineralized Allograft Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Demineralized Bone Matrix and Demineralized Allograft Producing Area Distribution and Sales Area
Table 23. Players Demineralized Bone Matrix and Demineralized Allograft Products Offered
Table 24. Demineralized Bone Matrix and Demineralized Allograft Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Demineralized Bone Matrix and Demineralized Allograft Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Share Geographic Region (2018-2023)
Table 29. Global Demineralized Bone Matrix and Demineralized Allograft Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Demineralized Bone Matrix and Demineralized Allograft Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Country/Region (2018-2023)
Table 33. Global Demineralized Bone Matrix and Demineralized Allograft Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Demineralized Bone Matrix and Demineralized Allograft Sales by Country (2018-2023) & (K Units)
Table 36. Americas Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Country (2018-2023)
Table 37. Americas Demineralized Bone Matrix and Demineralized Allograft Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Country (2018-2023)
Table 39. Americas Demineralized Bone Matrix and Demineralized Allograft Sales by Type (2018-2023) & (K Units)
Table 40. Americas Demineralized Bone Matrix and Demineralized Allograft Sales by Application (2018-2023) & (K Units)
Table 41. APAC Demineralized Bone Matrix and Demineralized Allograft Sales by Region (2018-2023) & (K Units)
Table 42. APAC Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Region (2018-2023)
Table 43. APAC Demineralized Bone Matrix and Demineralized Allograft Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Region (2018-2023)
Table 45. APAC Demineralized Bone Matrix and Demineralized Allograft Sales by Type (2018-2023) & (K Units)
Table 46. APAC Demineralized Bone Matrix and Demineralized Allograft Sales by Application (2018-2023) & (K Units)
Table 47. Europe Demineralized Bone Matrix and Demineralized Allograft Sales by Country (2018-2023) & (K Units)
Table 48. Europe Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Country (2018-2023)
Table 49. Europe Demineralized Bone Matrix and Demineralized Allograft Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Country (2018-2023)
Table 51. Europe Demineralized Bone Matrix and Demineralized Allograft Sales by Type (2018-2023) & (K Units)
Table 52. Europe Demineralized Bone Matrix and Demineralized Allograft Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Demineralized Bone Matrix and Demineralized Allograft
Table 60. Key Market Challenges & Risks of Demineralized Bone Matrix and Demineralized Allograft
Table 61. Key Industry Trends of Demineralized Bone Matrix and Demineralized Allograft
Table 62. Demineralized Bone Matrix and Demineralized Allograft Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Demineralized Bone Matrix and Demineralized Allograft Distributors List
Table 65. Demineralized Bone Matrix and Demineralized Allograft Customer List
Table 66. Global Demineralized Bone Matrix and Demineralized Allograft Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Demineralized Bone Matrix and Demineralized Allograft Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Demineralized Bone Matrix and Demineralized Allograft Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Demineralized Bone Matrix and Demineralized Allograft Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Demineralized Bone Matrix and Demineralized Allograft Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Demineralized Bone Matrix and Demineralized Allograft Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Demineralized Bone Matrix and Demineralized Allograft Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Demineralized Bone Matrix and Demineralized Allograft Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Demineralized Bone Matrix and Demineralized Allograft Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Medtronic Basic Information, Demineralized Bone Matrix and Demineralized Allograft Manufacturing Base, Sales Area and Its Competitors
Table 81. Medtronic Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
Table 82. Medtronic Demineralized Bone Matrix and Demineralized Allograft Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Medtronic Main Business
Table 84. Medtronic Latest Developments
Table 85. J &J (DePuy Synthes) Basic Information, Demineralized Bone Matrix and Demineralized Allograft Manufacturing Base, Sales Area and Its Competitors
Table 86. J &J (DePuy Synthes) Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
Table 87. J &J (DePuy Synthes) Demineralized Bone Matrix and Demineralized Allograft Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. J &J (DePuy Synthes) Main Business
Table 89. J &J (DePuy Synthes) Latest Developments
Table 90. SeaSpine Basic Information, Demineralized Bone Matrix and Demineralized Allograft Manufacturing Base, Sales Area and Its Competitors
Table 91. SeaSpine Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
Table 92. SeaSpine Demineralized Bone Matrix and Demineralized Allograft Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. SeaSpine Main Business
Table 94. SeaSpine Latest Developments
Table 95. Xtant Medical Basic Information, Demineralized Bone Matrix and Demineralized Allograft Manufacturing Base, Sales Area and Its Competitors
Table 96. Xtant Medical Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
Table 97. Xtant Medical Demineralized Bone Matrix and Demineralized Allograft Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Xtant Medical Main Business
Table 99. Xtant Medical Latest Developments
Table 100. Zimmer Biomet Basic Information, Demineralized Bone Matrix and Demineralized Allograft Manufacturing Base, Sales Area and Its Competitors
Table 101. Zimmer Biomet Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
Table 102. Zimmer Biomet Demineralized Bone Matrix and Demineralized Allograft Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Zimmer Biomet Main Business
Table 104. Zimmer Biomet Latest Developments
Table 105. Stryker Basic Information, Demineralized Bone Matrix and Demineralized Allograft Manufacturing Base, Sales Area and Its Competitors
Table 106. Stryker Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
Table 107. Stryker Demineralized Bone Matrix and Demineralized Allograft Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Stryker Main Business
Table 109. Stryker Latest Developments
Table 110. Straumann Basic Information, Demineralized Bone Matrix and Demineralized Allograft Manufacturing Base, Sales Area and Its Competitors
Table 111. Straumann Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
Table 112. Straumann Demineralized Bone Matrix and Demineralized Allograft Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Straumann Main Business
Table 114. Straumann Latest Developments
Table 115. Wright Medical Group Basic Information, Demineralized Bone Matrix and Demineralized Allograft Manufacturing Base, Sales Area and Its Competitors
Table 116. Wright Medical Group Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
Table 117. Wright Medical Group Demineralized Bone Matrix and Demineralized Allograft Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Wright Medical Group Main Business
Table 119. Wright Medical Group Latest Developments
Table 120. Hans Biomed Basic Information, Demineralized Bone Matrix and Demineralized Allograft Manufacturing Base, Sales Area and Its Competitors
Table 121. Hans Biomed Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
Table 122. Hans Biomed Demineralized Bone Matrix and Demineralized Allograft Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Hans Biomed Main Business
Table 124. Hans Biomed Latest Developments
Table 125. Arthrex Basic Information, Demineralized Bone Matrix and Demineralized Allograft Manufacturing Base, Sales Area and Its Competitors
Table 126. Arthrex Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
Table 127. Arthrex Demineralized Bone Matrix and Demineralized Allograft Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Arthrex Main Business
Table 129. Arthrex Latest Developments
List of Figures
Figure 1. Picture of Demineralized Bone Matrix and Demineralized Allograft
Figure 2. Demineralized Bone Matrix and Demineralized Allograft Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Demineralized Bone Matrix and Demineralized Allograft Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Demineralized Bone Matrix and Demineralized Allograft Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Gel
Figure 10. Product Picture of Putty
Figure 11. Product Picture of Putty with Chips
Figure 12. Product Picture of Others
Figure 13. Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Type in 2022
Figure 14. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Type (2018-2023)
Figure 15. Demineralized Bone Matrix and Demineralized Allograft Consumed in Dental Surgery
Figure 16. Global Demineralized Bone Matrix and Demineralized Allograft Market: Dental Surgery (2018-2023) & (K Units)
Figure 17. Demineralized Bone Matrix and Demineralized Allograft Consumed in Spine Surgery
Figure 18. Global Demineralized Bone Matrix and Demineralized Allograft Market: Spine Surgery (2018-2023) & (K Units)
Figure 19. Demineralized Bone Matrix and Demineralized Allograft Consumed in Trauma Surgery
Figure 20. Global Demineralized Bone Matrix and Demineralized Allograft Market: Trauma Surgery (2018-2023) & (K Units)
Figure 21. Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Application (2022)
Figure 22. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Application in 2022
Figure 23. Demineralized Bone Matrix and Demineralized Allograft Sales Market by Company in 2022 (K Units)
Figure 24. Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Company in 2022
Figure 25. Demineralized Bone Matrix and Demineralized Allograft Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Company in 2022
Figure 27. Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Demineralized Bone Matrix and Demineralized Allograft Sales 2018-2023 (K Units)
Figure 30. Americas Demineralized Bone Matrix and Demineralized Allograft Revenue 2018-2023 ($ Millions)
Figure 31. APAC Demineralized Bone Matrix and Demineralized Allograft Sales 2018-2023 (K Units)
Figure 32. APAC Demineralized Bone Matrix and Demineralized Allograft Revenue 2018-2023 ($ Millions)
Figure 33. Europe Demineralized Bone Matrix and Demineralized Allograft Sales 2018-2023 (K Units)
Figure 34. Europe Demineralized Bone Matrix and Demineralized Allograft Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Revenue 2018-2023 ($ Millions)
Figure 37. Americas Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Country in 2022
Figure 38. Americas Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Country in 2022
Figure 39. Americas Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Type (2018-2023)
Figure 40. Americas Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Application (2018-2023)
Figure 41. United States Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Region in 2022
Figure 46. APAC Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Regions in 2022
Figure 47. APAC Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Type (2018-2023)
Figure 48. APAC Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Application (2018-2023)
Figure 49. China Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Country in 2022
Figure 57. Europe Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Country in 2022
Figure 58. Europe Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Type (2018-2023)
Figure 59. Europe Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Application (2018-2023)
Figure 60. Germany Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Application (2018-2023)
Figure 69. Egypt Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Demineralized Bone Matrix and Demineralized Allograft in 2022
Figure 75. Manufacturing Process Analysis of Demineralized Bone Matrix and Demineralized Allograft
Figure 76. Industry Chain Structure of Demineralized Bone Matrix and Demineralized Allograft
Figure 77. Channels of Distribution
Figure 78. Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Forecast by Region (2024-2029)
Figure 79. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share Forecast by Application (2024-2029)

※参考情報 脱灰骨基質（Demineralized Bone Matrix, DBM）および脱灰同種移植片（Demineralized Allograft）は、骨再生を促進するために用いられる生体材料であり、様々な臨床での応用が見込まれています。これらは特に、外科的な骨の修復や再生を必要とする状況で重宝されます。以下に、これらの概念について詳細に説明いたします。 まず、脱灰骨基質の定義について述べます。脱灰骨基質とは、骨組織からミネラル成分を除去した後の骨基質を指します。通常、骨は細胞外マトリックスと呼ばれる有機成分（コラーゲンや非コラーゲンタンパク質）と、リン酸カルシウムなどのミネラル成分から構成されています。このプロセスにより、骨の力学的強度は低下しますが、有機成分が残るため、細胞の増殖や分化を促進する環境を提供します。 次に、脱灰骨基質の特徴について説明します。脱灰骨基質は、主に以下の特徴を持っています。第一に、生体適合性があります。すなわち、体内に移植した際に拒絶反応が起こりにくく、周囲の組織と調和しやすいです。第二に、骨誘導性があります。新しい骨組織の形成を促進するための成分が多く含まれており、特に成長因子（例えば、BMP: Bone Morphogenetic Proteins）がその代表です。第三に、医療現場での取り扱いやすさも挙げられます。脱灰骨基質は、様々な形状やサイズに加工されるため、特定の手術に応じて利用が可能です。 脱灰同種移植片についても似たような特徴を持っていますが、さらに異なる点も存在します。脱灰同種移植片は、他の人から提供された骨組織であり、これは適切な処理が行われた後に移植されます。脊椎手術や関節外科、さらに顎顔面外科においても広く利用されています。この移植片も生体適合性が高く、拒絶反応のリスクが低いとされています。 これらの材料は、いくつかの種類に分類されます。代表的なものとして、液体状のもの、ペースト状のもの、およびグラニュール状のものがあります。用途に応じて選択され、例えば大きな骨の欠損にはグラニュール状が用いられ、小さな範囲にはペースト状のものが好まれることがあります。 脱灰骨基質および脱灰同種移植片の用途は多岐にわたります。骨の再生や修復に加え、骨形成を促進させるために、歯科治療や整形外科手術において活用されています。また、骨形成が期待できる領域にばら撒くことによって、自己骨の代替としての機能も果たします。特に、金属インプラントと組み合わせて使用することが多く、これらの材料は生体内で新しい骨の形成をさらに促進することができます。 関連技術としては、成長因子の添加、3Dプリンティング技術、幹細胞技術などがあります。成長因子の添加によって、その誘導能力が増強され、より早い骨再生が期待できるようになります。また、3Dプリンティング技術を活用することで、患者の特定の解剖学的構造に適したカスタマイズされた移植片を作成することが可能です。幹細胞技術は、より高い骨形成能力を持つ細胞を移植することで、再生をさらに促進する手法です。 最後に、脱灰骨基質および脱灰同種移植片に関する将来的な展望について考察します。これらの材料は、骨再生の分野でますます重要性を増しており、今後の研究によってその適用範囲が広がることが期待されています。特に、再生医療の進展に伴って、より効果的な骨再生の方法が開発される可能性があります。また、これらの材料を用いた治療法がより個別化されることで、患者ごとの最適な治療が可能となるでしょう。 脱灰骨基質および脱灰同種移植片は、骨の再生において欠かせない材料であり、今後も医療現場での利用が進むことが予想されます。研究と技術の進展により、これらの材料がさらに進化し、患者のQOL向上に寄与することを期待しています。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer